1. Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC‐46). (16th June 2020) Authors: De Ridder, Thomas R.; Campbell, Justine E.; Burke‐Schwarz, Cheryl; Clegg, David; Elliot, Emily L.; Geller, Samuel; Kozak, Wendy; Pittenger, Stephen T.; Pruitt, Jennifer B.; Riehl, Jocelyn; White, Julie; Wiest, Melissa L.; Johannes, Chad M.; Morton, John; Jones, Pamela D.; Schmidt, Peter F.; Gordo... Journal: Journal of veterinary internal medicine Issue: Volume 35:Number 1(2021) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate. (12th January 2021) Authors: Reddell, Paul; De Ridder, Thomas R.; Morton, John M.; Jones, Pamela D.; Campbell, Justine E.; Brown, Graham; Johannes, Chad M.; Schmidt, Peter F.; Gordon, Victoria Journal: Journal of veterinary internal medicine Issue: Volume 35:Number 1(2021) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗